A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer
Clinical trial NCT06636435 · RECRUITING
Trial details
- NCT number
- NCT06636435
- Sponsor
- Chiome Bioscience Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2027-06-30
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.